Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

09 June 2000

Surrogate Biomarkers of Long-term Outcome after Kidney Transplantation

Leendert C Paul

Ann Transplant 2000; 5(2): 5-6 :: ID: 497518

Abstract

A recent analysis of the USRDS material has shown that the median cadaveric renal transplant survival has improved from 64.5 months in 1986-1987 to 101.8 months in 1992-1993[1], an improvement of almost 60%. The reason for this improved outcome is multifactorial and reflects very likely improved patient survival, increasing experience, and more potent immunosuppression. Chronic rejection remains the main reason for graft failure with censoring for death with a functioning transplant.

Keywords: chronic rejection, Kidney Transplantation, long term outcome

Add Comment 0 Comments

In Press

Original article  

Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...

Ann Transplant In Press; DOI: 10.12659/AOT.953761  

Clinical Research  

Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...

Ann Transplant In Press; DOI: 10.12659/AOT.954230  

Clinical Research  

Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...

Ann Transplant In Press; DOI: 10.12659/AOT.954574  

Most Viewed Current Articles

24 Aug 2021 : Review article   21,978

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

29 Dec 2021 : Original article   18,247

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

22 Nov 2022 : Original article   16,856

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

05 Apr 2022 : Original article   16,762

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358